Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx-1.

Yupu Lu Yuying KouYuan GaoPanpan YangShanshan LiuFan ZhangMinqi Li

Published in: Oral diseases (2021)

Eldecalcitol may inhibit the progression of oral cancer by suppressing the expression of glutathione peroxidase-1, which may provide new insight into the application of eldecalcitol as a potential anti-cancer drug.

Keyphrases

poor prognosis
binding protein
hydrogen peroxide
emergency department
nitric oxide
risk assessment